
|Articles|June 2, 2017
Advancements in Asthma Therapy and Their Impact on Managed Care
Advertisement
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Newer Agents, New Advantages: Brexpiprazole, Cariprazine, and Lumateperone in MDD
2
Dosing, Tolerability, and Formulary Impact: Aripiprazole and Quetiapine XR in MDD
3
60% of US Women Face Barriers to Postpartum, Mental Health Care
4
5 August FDA Approvals Marked by Novelty, Pushback
5




